Arbutus Biopharma Corporation ( ABUS ) is currently at $2.96, down $0.27 or 8.2%
--Would be lowest close since June 20, 2024, when it closed at $2.95
--On pace for largest percent decrease since April 25, 2023, when it fell 12.46%
--Currently down two consecutive days; down 15.53% over this period
--Worst two day stretch since the two days ending April 25, 2023, when it fell 15.67%
--Down 15.04% month-to-date
--Down 9.33% year-to-date
--Down 90.42% from its all-time closing high of $30.94 on March 11, 2014
--Down 4.05% from 52 weeks ago (April 8, 2024), when it closed at $3.09
--Down 34.98% from its 52-week closing high of $4.56 on Sept. 11, 2024
--Up 12.31% from its 52-week closing low of $2.64 on April 22, 2024
--Traded as low as $2.89; lowest intraday level since May 17, 2024, when it hit $2.89
--Down 10.53% at today's intraday low; largest intraday percent decrease since Aug. 5, 2024, when it fell as much as 11.65%
All data as of 11:17:43 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 07, 2025 11:20 ET (15:20 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。